 | • レポートコード：QFJ1-4086 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、シクロオキシゲナーゼ2阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（選択的コックス2阻害剤、非選択的コックス2阻害剤）、用途別市場規模（病院、専門診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・シクロオキシゲナーゼ2阻害剤の市場動向 ・企業の競争状況、市場シェア ・シクロオキシゲナーゼ2阻害剤の種類別市場規模と予測2016-2027（選択的コックス2阻害剤、非選択的コックス2阻害剤） ・シクロオキシゲナーゼ2阻害剤の用途別市場規模と予測2016-2027（病院、専門診療所、その他） ・シクロオキシゲナーゼ2阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・シクロオキシゲナーゼ2阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・シクロオキシゲナーゼ2阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・シクロオキシゲナーゼ2阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・シクロオキシゲナーゼ2阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Bayer、Novartis、Merck、Sabinsa、Cadila Pharmaceuticals、Mylan、Teva Pharmaceutical、Alembic Pharmaceutical、Aurobindo Pharma、Cipla、Torrent Pharmaceuticals） ・結論 |
COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has extremely low activity in normal tissue cells, and can only be produced in large quantities when induced. It mediates pain, inflammation, and fever by promoting PG synthesis. In general, multiple adverse effects of non-steroidal anti-inflammatory drugs are believed to be related to the inhibition of COX-1. As a result, COX-2 selective inhibitors have emerged.
Market Analysis and Insights: Global Cyclooxygenase 2 Inhibitor Market
The global Cyclooxygenase 2 Inhibitor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cyclooxygenase 2 Inhibitor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cyclooxygenase 2 Inhibitor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cyclooxygenase 2 Inhibitor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cyclooxygenase 2 Inhibitor market.
Global Cyclooxygenase 2 Inhibitor Scope and Market Size
Cyclooxygenase 2 Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cyclooxygenase 2 Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Selective Cox 2 Inhibitor
Non-Selective Cox 2 Inhibitor
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Bayer
Novartis
Merck
Sabinsa
Cadila Pharmaceuticals
Mylan
Teva Pharmaceutical
Alembic Pharmaceutical
Aurobindo Pharma
Cipla
Torrent Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Selective Cox 2 Inhibitor
1.2.3 Non-Selective Cox 2 Inhibitor
1.3 Market by Application
1.3.1 Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cyclooxygenase 2 Inhibitor Market Perspective (2016-2027)
2.2 Cyclooxygenase 2 Inhibitor Growth Trends by Regions
2.2.1 Cyclooxygenase 2 Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cyclooxygenase 2 Inhibitor Historic Market Share by Regions (2016-2021)
2.2.3 Cyclooxygenase 2 Inhibitor Forecasted Market Size by Regions (2022-2027)
2.3 Cyclooxygenase 2 Inhibitor Industry Dynamic
2.3.1 Cyclooxygenase 2 Inhibitor Market Trends
2.3.2 Cyclooxygenase 2 Inhibitor Market Drivers
2.3.3 Cyclooxygenase 2 Inhibitor Market Challenges
2.3.4 Cyclooxygenase 2 Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue
3.1.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue (2016-2021)
3.1.2 Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Players (2016-2021)
3.2 Global Cyclooxygenase 2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cyclooxygenase 2 Inhibitor Revenue
3.4 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio
3.4.1 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclooxygenase 2 Inhibitor Revenue in 2020
3.5 Cyclooxygenase 2 Inhibitor Key Players Head office and Area Served
3.6 Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
3.7 Date of Enter into Cyclooxygenase 2 Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cyclooxygenase 2 Inhibitor Breakdown Data by Type
4.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Type (2016-2021)
4.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2022-2027)
5 Cyclooxygenase 2 Inhibitor Breakdown Data by Application
5.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Application (2016-2021)
5.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
6.2 North America Cyclooxygenase 2 Inhibitor Market Size by Type
6.2.1 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
6.2.2 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
6.2.3 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
6.3 North America Cyclooxygenase 2 Inhibitor Market Size by Application
6.3.1 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
6.3.2 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
6.3.3 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
6.4 North America Cyclooxygenase 2 Inhibitor Market Size by Country
6.4.1 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
6.4.2 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
7.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Type
7.2.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
7.2.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
7.2.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
7.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Application
7.3.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
7.3.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
7.3.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
7.4 Europe Cyclooxygenase 2 Inhibitor Market Size by Country
7.4.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
7.4.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
8.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type
8.2.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
8.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application
8.3.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
8.4 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region
8.4.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
9.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type
9.2.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
9.2.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
9.2.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
9.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application
9.3.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
9.3.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
9.3.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
9.4 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country
9.4.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
9.4.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
10.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type
10.2.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
10.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application
10.3.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
10.4 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country
10.4.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cyclooxygenase 2 Inhibitor Introduction
11.1.4 Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Cyclooxygenase 2 Inhibitor Introduction
11.2.4 Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Cyclooxygenase 2 Inhibitor Introduction
11.3.4 Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Cyclooxygenase 2 Inhibitor Introduction
11.4.4 Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Sabinsa
11.5.1 Sabinsa Company Details
11.5.2 Sabinsa Business Overview
11.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Introduction
11.5.4 Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.5.5 Sabinsa Recent Development
11.6 Cadila Pharmaceuticals
11.6.1 Cadila Pharmaceuticals Company Details
11.6.2 Cadila Pharmaceuticals Business Overview
11.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction
11.6.4 Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.6.5 Cadila Pharmaceuticals Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Cyclooxygenase 2 Inhibitor Introduction
11.7.4 Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction
11.8.4 Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Alembic Pharmaceutical
11.9.1 Alembic Pharmaceutical Company Details
11.9.2 Alembic Pharmaceutical Business Overview
11.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction
11.9.4 Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.9.5 Alembic Pharmaceutical Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Introduction
11.10.4 Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.10.5 Aurobindo Pharma Recent Development
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla Cyclooxygenase 2 Inhibitor Introduction
11.11.4 Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.11.5 Cipla Recent Development
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Company Details
11.12.2 Torrent Pharmaceuticals Business Overview
11.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction
11.12.4 Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.12.5 Torrent Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Selective Cox 2 Inhibitor
Table 3. Key Players of Non-Selective Cox 2 Inhibitor
Table 4. Global Cyclooxygenase 2 Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cyclooxygenase 2 Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cyclooxygenase 2 Inhibitor Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2016-2021)
Table 8. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2022-2027)
Table 10. Cyclooxygenase 2 Inhibitor Market Trends
Table 11. Cyclooxygenase 2 Inhibitor Market Drivers
Table 12. Cyclooxygenase 2 Inhibitor Market Challenges
Table 13. Cyclooxygenase 2 Inhibitor Market Restraints
Table 14. Global Cyclooxygenase 2 Inhibitor Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cyclooxygenase 2 Inhibitor Market Share by Players (2016-2021)
Table 16. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2020)
Table 17. Ranking of Global Top Cyclooxygenase 2 Inhibitor Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cyclooxygenase 2 Inhibitor Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
Table 21. Date of Enter into Cyclooxygenase 2 Inhibitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2016-2021)
Table 25. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cyclooxygenase 2 Inhibitor Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2016-2021)
Table 29. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Cyclooxygenase 2 Inhibitor Product
Table 64. Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Cyclooxygenase 2 Inhibitor Product
Table 69. Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Cyclooxygenase 2 Inhibitor Product
Table 74. Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Cyclooxygenase 2 Inhibitor Product
Table 79. Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Sabinsa Company Details
Table 82. Sabinsa Business Overview
Table 83. Sabinsa Cyclooxygenase 2 Inhibitor Product
Table 84. Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 85. Sabinsa Recent Development
Table 86. Cadila Pharmaceuticals Company Details
Table 87. Cadila Pharmaceuticals Business Overview
Table 88. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product
Table 89. Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 90. Cadila Pharmaceuticals Recent Development
Table 91. Mylan Company Details
Table 92. Mylan Business Overview
Table 93. Mylan Cyclooxygenase 2 Inhibitor Product
Table 94. Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 95. Mylan Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceutical Recent Development
Table 100. Alembic Pharmaceutical Company Details
Table 101. Alembic Pharmaceutical Business Overview
Table 102. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product
Table 103. Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 104. Alembic Pharmaceutical Recent Development
Table 105. Aurobindo Pharma Company Details
Table 106. Aurobindo Pharma Business Overview
Table 107. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product
Table 108. Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 109. Aurobindo Pharma Recent Development
Table 110. Cipla Company Details
Table 111. Cipla Business Overview
Table 112. Cipla Cyclooxygenase 2 Inhibitor Product
Table 113. Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 114. Cipla Recent Development
Table 115. Torrent Pharmaceuticals Company Details
Table 116. Torrent Pharmaceuticals Business Overview
Table 117. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product
Table 118. Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 119. Torrent Pharmaceuticals Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cyclooxygenase 2 Inhibitor Market Share by Type: 2020 VS 2027
Figure 2. Selective Cox 2 Inhibitor Features
Figure 3. Non-Selective Cox 2 Inhibitor Features
Figure 4. Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Cyclooxygenase 2 Inhibitor Report Years Considered
Figure 9. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cyclooxygenase 2 Inhibitor Market Share by Regions: 2020 VS 2027
Figure 12. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2022-2027)
Figure 13. Global Cyclooxygenase 2 Inhibitor Market Share by Players in 2020
Figure 14. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cyclooxygenase 2 Inhibitor Revenue in 2020
Figure 16. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2016-2021)
Figure 17. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2022-2027)
Figure 18. North America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 20. North America Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 21. North America Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 22. United States Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 26. Europe Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 27. Europe Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 28. Germany Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Region (2016-2027)
Figure 38. China Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 46. Latin America Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 47. Latin America Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 48. Mexico Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 54. Turkey Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 61. Sabinsa Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 62. Cadila Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 65. Alembic Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 66. Aurobindo Pharma Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 67. Cipla Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 68. Torrent Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年） The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. The high efficacy of EGFR inhibitors in the treatment of various types of cancer indicati…- 世界のVEGF阻害薬市場規模・現状・予測（2021年-2027年） Vascular endothelial growth factor (VEGF) is an angiogenic factor responsible for the formation of blood vessels either from already existing blood vessels or from vascular endothelial cells. Market Analysis and Insights: Global VEGF Inhibitor Drugs Market The global VEGF Inhibitor Drugs market size…
- 世界の酵素ポリADPリボースポリメラーゼ阻害剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market The global Enzyme Poly ADP Ribose Polymerase Inhibitor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の腫瘍壊死因子（TNF）阻害薬市場規模・現状・予測（2021年-2027年） A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, …
- 世界の酵素ポリADPリボースポリメラーゼ（PARP）阻害剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market The global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standar…